Dr. Reddy's Laboratories (NYSE:RDY) Downgraded by StockNews.com

StockNews.com downgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Separately, Barclays lifted their price objective on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note on Wednesday, May […]

Related Keywords

Wellington ,New Zealand General ,New Zealand , ,Barclays ,Wellington Management Group ,Sequoia Financial Advisors ,Fisher Asset Management ,Reddy Laboratories ,Allspring Global Investments Holdings ,Free Report ,Global Investments Holdings ,Financial Advisors ,Management Group ,Asset Management ,Nordea Investment Management ,Investment Management ,Get Free Report ,Laboratories Limited ,Global Generics ,Pharmaceutical Services ,Active Ingredients ,Laboratories Daily ,